Clarus Partners - AkuCert Named Best FinTech for Tax Management
AkuCert named 'Best FinTech for Tax Management' in 2025 FinTech Awards presented by The Cloud Awards
'AkuCert provides a powerful tool to both comply with requirements and monitor submissions across multiple jurisdictions; their cloud-based service improves access and visibility for clients...'— Stephen Backhouse, Lead Judge at The FinTech Awards
COLUMBUS, OH, UNITED STATES, April 22, 2025 / EINPresswire.com / -- Clarus Partners Advisors has been named the winner of the 'Best FinTech for Tax Management' award at the 2025 FinTech Awards, a prestigious global program recognizing innovation and excellence in financial technology. Clarus earned top honors for its cutting-edge exemption certificate management solution, AkuCert, developed to simplify and transform how businesses maintain compliance with sales and use tax regulations.
The FinTech Awards, operated by the internationally recognized Cloud Awards, celebrate financial technology solutions that are reshaping the future of finance. This year's competition drew entries from top innovators across North America, the UK, Europe, the Middle East, and the Asia-Pacific region.
'AkuCert provides a powerful tool to both comply with requirements and monitor submissions across multiple jurisdictions; their cloud-based service improves access and visibility for clients and professionals alike,' said Stephen Backhouse, Lead Judge at The FinTech Awards. 'By continually updating their libraries and focusing on their clients, AkuCert has been able to almost eliminate losses from incorrect record keeping in a highly technical sector of tax compliance. Congratulations to Clarus Partners Advisors from everyone at The FinTech Awards.'
AkuCert is part of the proprietary AkuSuite platform and is the only suite of sales and use tax software developed and supported by experienced indirect tax professionals. The software automates exemption certificate collection, validation, and audit readiness, delivering unparalleled accuracy, efficiency, and peace of mind for finance teams.
Jeff Mallory, CEO of Clarus Partners, shared:
'Winning the 'Best FinTech for Tax Management' award is a powerful affirmation of our mission: to bring clarity and confidence to tax compliance through purpose-built technology. This recognition underscores our team's dedication to creating intelligent tools that solve real challenges for businesses.'
With an unparalleled reputation for sales & use tax services, Clarus Partners offers the only suite of tax software solutions in the industry created and serviced by indirect tax professionals. The AkuSuite software suite includes:
AkuCalc: Clear & Critical Sales and Use Tax Calculation Software
AkuCert: Clear & Critical Sales and Use Tax Exemption Certificate Management Software (ECMS)
AkuLicense: Clear & Comprehensive Business License Management Software
All Clarus software solutions integrate with leading ERP and accounting platforms, ensuring seamless financial operations for businesses. Most importantly, these solutions are supported by indirect tax specialists who bring professional expertise to software automation.
To learn more about Clarus Partners and request a demo of any AkuSuite software solutions, visit https://www.claruspartners.com/ or call 614-362-2730.
About Clarus Partners Advisors, LLC
Headquartered in Columbus, OH, Clarus Partners Advisors LLC provides clear, confident, and concise indirect tax consulting and compliance services through a combination of onsite resources and offsite support. Services include sales tax compliance, sales tax consulting, exemption certificate management, indirect tax outsourcing, business license compliance, and unclaimed property solutions. Clarus Partners is the developer of AkuSuite, the only suite of tax software solutions created and serviced by indirect tax professionals. Learn more at https://www.claruspartners.com/.
Steve Hanebutt
Clarus Partners
+1 614-362-2730
email us here
Visit us on social media:
Facebook
LinkedIn
Instagram
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
ZEISS CLARUS 700 Receives NMPA Approval in China
ZEISS Medical Technology expands retinal insights for ophthalmologists with ultra-widefield, high-resolution imaging capabilities JENA, Germany and SHANGHAI, June 5, 2025 /CNW/ -- ZEISS Medical Technology announced today that the CLARUS® 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality. The fundus imaging device with Fluorescein Angiography helps eye care specialists in China unlock the full potential of their clinic's retina workflow to support improved patient vision preservation. "ZEISS CLARUS 700 represents a major step forward in retinal imaging," emphasizes Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology. "By seamlessly integrating ultra-widefield Fluorescein Angiography (FA) imaging with true-color reproduction, this system delivers unprecedented clarity for comprehensive visualization from the macular region to the extreme retinal periphery, enhancing efficiency and supporting precise decision-making within the ZEISS Retina Workflow." "Integrating ultra-widefield imaging, unsurpassed clarity, and AI-enhanced capture, the CLARUS 700 redefines fundus angiography benchmarks. It will provide unparalleled diagnostic precision for Chinese doctors and unprecedented comfort for their patients," says Maxwell Liu, Head of Sales & Services at ZEISS Medical Technology China. Ultra-widefield fluorescein angiography serves as a highly valuable examination tool for assessing nonperfused retinal areas. The ZEISS CLARUS 700 HD ultra-widefield fundus imaging camera is an advanced retinal imaging system that provides True Color, high-resolution images. It captures 133°1 in a single image and up to 267° with multiple captures, offering detailed views of the retina. Equipped with both fluorescein angiography and live infrared imaging capabilities, the CLARUS 700 aids in diagnosing and monitoring retinal diseases2. Furthermore, the fundus imaging camera offers innovative technology features including PrecisionFocus for quickly seeing details in the regions of interest, QuickCompare to compare pathology changes observed in past patient visits, and AutoBright so ophthalmologists can spend more time analyzing images and less time adjusting them. More information about the CLARUS® 700 from ZEISS can be found here. 1 CLARUS 700#white-paper2 Xiao, Y., Dan, H., Du, X. et al. Assessment of early diabetic retinopathy severity using ultra-widefield Clarus versus conventional five-field and ultra-widefield Optos fundus imaging. Sci Rep 13, 17131 (2023). Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support. Contact for investorsSebastian FrericksDirector Investor RelationsCarl Zeiss Meditec AGPhone: +49 3641 220 116Mail: Contact for the pressFrank SmithHead of Global Communications OphthalmologyCarl Zeiss Meditec +49 3641 220 331Mail: Brief Profile Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September). The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. For further information visit: View original content to download multimedia: SOURCE Carl Zeiss Meditec AG View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 hours ago
- Yahoo
ZEISS CLARUS 700 Receives NMPA Approval in China
ZEISS Medical Technology expands retinal insights for ophthalmologists with ultra-widefield, high-resolution imaging capabilities JENA, Germany and SHANGHAI, June 5, 2025 /CNW/ -- ZEISS Medical Technology announced today that the CLARUS® 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality. The fundus imaging device with Fluorescein Angiography helps eye care specialists in China unlock the full potential of their clinic's retina workflow to support improved patient vision preservation. "ZEISS CLARUS 700 represents a major step forward in retinal imaging," emphasizes Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology. "By seamlessly integrating ultra-widefield Fluorescein Angiography (FA) imaging with true-color reproduction, this system delivers unprecedented clarity for comprehensive visualization from the macular region to the extreme retinal periphery, enhancing efficiency and supporting precise decision-making within the ZEISS Retina Workflow." "Integrating ultra-widefield imaging, unsurpassed clarity, and AI-enhanced capture, the CLARUS 700 redefines fundus angiography benchmarks. It will provide unparalleled diagnostic precision for Chinese doctors and unprecedented comfort for their patients," says Maxwell Liu, Head of Sales & Services at ZEISS Medical Technology China. Ultra-widefield fluorescein angiography serves as a highly valuable examination tool for assessing nonperfused retinal areas. The ZEISS CLARUS 700 HD ultra-widefield fundus imaging camera is an advanced retinal imaging system that provides True Color, high-resolution images. It captures 133°1 in a single image and up to 267° with multiple captures, offering detailed views of the retina. Equipped with both fluorescein angiography and live infrared imaging capabilities, the CLARUS 700 aids in diagnosing and monitoring retinal diseases2. Furthermore, the fundus imaging camera offers innovative technology features including PrecisionFocus for quickly seeing details in the regions of interest, QuickCompare to compare pathology changes observed in past patient visits, and AutoBright so ophthalmologists can spend more time analyzing images and less time adjusting them. More information about the CLARUS® 700 from ZEISS can be found here. 1 CLARUS 700#white-paper2 Xiao, Y., Dan, H., Du, X. et al. Assessment of early diabetic retinopathy severity using ultra-widefield Clarus versus conventional five-field and ultra-widefield Optos fundus imaging. Sci Rep 13, 17131 (2023). Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support. Contact for investorsSebastian FrericksDirector Investor RelationsCarl Zeiss Meditec AGPhone: +49 3641 220 116Mail: Contact for the pressFrank SmithHead of Global Communications OphthalmologyCarl Zeiss Meditec +49 3641 220 331Mail: Brief Profile Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September). The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries. For further information visit: View original content to download multimedia: SOURCE Carl Zeiss Meditec AG View original content to download multimedia:
USA Today
6 days ago
- USA Today
San Ramon Welcomes Executive Base Network's Flexible Office Space Solutions
San Ramon, California – Executive Base Network, a San Ramon-based office space provider, recently rolled out a service offering flexible office solutions for companies looking for fully featured workspace solutions tailored to meet modern business needs. This service includes Full-Time Office Packages where independent professionals can enjoy furnished spaces with high-speed internet and 24/7 access, perfectly addressing the demands of freelancers. For businesses seeking to project a professional image without the commitment to a physical space, their Virtual Office Packages offer a credible business address, live receptionist services, and access to office facilities as needed. Their Meeting Room Rentals stand out as a cost-effective option for businesses needing professional meeting spaces, equipped with cutting-edge technology such as a 65″ Samsung monitor and Clarus glassboard, and starting at affordable hourly rates. Meanwhile, their Private Offices On Demand facilitate access to fully equipped private offices with flexible rental terms, starting as low as $20 per hour. This diversified approach allows businesses to access a professional workspace tailored exactly to their needs, whether regularly or occasionally. 'As businesses evolve, so too should their work environments,' said Tara Teodoro of Executive Base Network. 'Our goal is to provide a flexible and hassle-free workspace experience that enables businesses to thrive without being tied to excessive costs or limitations. The current landscape demands adaptable solutions, and our service aims to meet those requirements.' In addressing the changing demands of workplaces, Executive Base Network offers services that seamlessly adjust to fluctuations in business needs, enabling rapid scaling in response to economic shifts. Administrative support and maintenance services form part of this comprehensive package, ensuring clients have everything required to focus on their primary objectives. Beyond providing workspaces, Executive Base Network is committed to building a community that supports business success. With strategic locations in urban and suburban areas, they reduce commute times and promote a healthier work-life balance for their clients. While adapting to current market trends, Executive Base Network remains dedicated to fulfilling its clients' needs with a forward-thinking approach. The company emphasizes that this new workspace initiative marks a move toward redefining what a modern office can be. Overall, Executive Base Network's introduction of flexible office solutions addresses the need for more dynamic, economical, and efficient work environments. With an emphasis on adaptability and client satisfaction, this service offers a tailored approach to keep up with the ever-changing needs of modern businesses. Further details about the variety of workspace solutions offered can be explored directly through their website.
